Chronic cough, defined as a cough lasting more than eight weeks, presents a common yet complex challenge in clinical practice. Despite its prevalence, the etiology often remains elusive, leading to diagnostic uncertainty and therapeutic dilemmas. This article aims to illuminate a comprehensive approach to diagnosing and managing chronic cough.
Chronic cough can be attributed to a myriad of causes, from common conditions like asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS) to less prevalent etiologies like lung cancer. A detailed patient history coupled with targeted investigations can help pinpoint the underlying cause.
The diagnostic approach should be systematic and patient-centric. Initial evaluation should include a thorough history and physical examination, focusing on identifying common causes and risk factors. If the cause is not readily apparent, further investigations such as imaging, spirometry, and bronchoscopy may be warranted. Empirical therapy can be considered in certain cases, but should not delay definitive diagnosis.
Management should be tailored based on the identified etiology. For instance, asthma-related cough may respond well to inhaled corticosteroids, while GERD-associated cough may require proton pump inhibitors. Non-pharmacological interventions, such as lifestyle modifications and physiotherapy, can also play a crucial role. Refractory cases may necessitate referral to a specialist.
Research is ongoing to develop novel diagnostic tools and therapeutic options for chronic cough. Emerging modalities like cough reflex testing and potential new drugs targeting neural pathways are promising. More studies are needed to validate their efficacy and safety.
Chronic cough is a multifaceted problem requiring a comprehensive and individualized approach. By maintaining a high index of suspicion, employing a systematic diagnostic strategy, and tailoring management based on etiology, clinicians can effectively diagnose and manage this common but often perplexing condition.
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
How wildfires pose challenges to cancer care
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Advanced Directions in Oncology and Quality Improvement
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
When Unexplained Bruising May Require Blood Testing
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation